Viracta Therapeutics' Series B - III Round

Viracta Therapeutics raised a round of funding on July 13, 2010. Investors include Latterell Venture Partners.

Viracta Therapeutics, formerly Hemaquest Pharmaceuticals, is a clinical-stage drug development company focused on advancing a proprietary viral activation therapy platform to address cancers associate…

Articles about Viracta Therapeutics' Series B - III Round: